19 June 2013
Keywords: millennium, gets, first, approval, myeloma, drug, velcade
Article | 19 May 2003
Millennium Pharmaceuticals has won US approval for Velcade (bortezomib), the first in a new class of proteasome inhibitors, as a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 July 2003
21 July 2003
28 July 2003
© 2013 thepharmaletter.com